Bandaram Pharma Packtech Ltd.

View in App
34.00 -0.60 ▼-1.7%

30 April 2024, 04:01:00 PM
Volume: 4,038

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bandaram.com
Market Cap 40.80 Cr.
Enterprise Value(EV) 46.03 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.73 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 46.79 Trailing Twelve Months Ending 2023-12
Industry PE 42.18 Trailing Twelve Months Ending 2023-12
Book Value / Share 10.52 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.23 Calculated using Price: 34.00
Dividend Yield 0.29 Period Ending 2023-03
No. of Shares Subscribed 1.20 Cr. 12,000,000 Shares
FaceValue 10
About Bandaram Pharma Packtech Ltd.
The company engaged in manufacturing of paper products and packing materials with more focus on catering to the needs of pharma, food and beverages industry.

Bandaram Pharma Packtech Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Bandaram Pharma Packtech Ltd. Performance

View details >>
1 Day
-1.73%
1 Week
+7.77%
1 Month
-8.26%
3 Month
+5.52%
6 Month
+16.32%
1 Year
+33.96%
2 Year
+574.60%
5 Year
+488.24%
10 Year
+18788.89%

Bandaram Pharma Packtech Ltd. Fundamental Ratios

View details >>
1 years 2023-03
Return on Equity (%) 8.4
Return on Capital Employed (%) 4.39
Return on Assets (%) 1.28

Bandaram Pharma Packtech Ltd. Balance Sheet

View details >>
Particulars 2 years 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 3 12
Non Curr. Liab. 8 5
Curr. Liab. 7 7
Minority Int. 2 2
Equity & Liab. 20 26
Non Curr. Assets 5 8
Curr. Assets 15 18
Misc. Exp. not W/O 0
Total Assets 20 26

Bandaram Pharma Packtech Ltd. Profit and Loss

View details >>
Particulars 2 years 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 19 31
Other Income 0 0
Total Income 19 31
Total Expenditure -18 -28
PBIDT 1 3
Interest 0 -1
Depreciation -1 -1
Taxation 0 0
Exceptional Items
PAT 0 1
Minority Interest 0 0
Share Associate
Other Related Items
Consolidated Net Profit 0 1
Adjusted EPS 0 1

Bandaram Pharma Packtech Ltd. Cash Flow

View details >>
Particulars 1 years 2023-03 Rs. Cr.
Cash Fr. Operatn. -1
Cash Fr. Inv. -5
Cash Fr. Finan. 4
Net Change -2
Cash & Cash Eqvt 0

Bandaram Pharma Packtech Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00
Public 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Bandaram Pharma Packtech Ltd. Announcements

View details >>
Tue, 23 Apr 2024
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Bandaram Pharma Packtech Ltd
2 CIN NO. L93090KA1993PLC159827
3 Report filed for FY 2023-2024
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* 0
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
8Quantum of (d) which has been met from (c)(e)* 0
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)0
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-Neha Kankariya
Designation :-Company Secretary and Compliance Officer
Name of the Chief Financial Officer :- Shiva Kumar Vellanki
Designation : -CFO

Date: 23/04/2024
Fri, 19 Apr 2024
Disclosure Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
Disclosure under reg. 40 (9) of SEBI (LODR) Reg. 2015
Tue, 16 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliance Certificate under reg. 74(5) of SEBI (DP) Reg. 2018

Bandaram Pharma Packtech Ltd. Technical Scans

View details >>
Mon, 29 Apr 2024
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Opening at Low Opening at Low
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 1 Year High Increase in 1 Year

Bandaram Pharma Packtech Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 365,166.79 1,502.30 -1.3%
Cipla Ltd. 113,644.88 1,402.20 -0.4%
Divi's Laboratories Ltd. 105,890.11 3,999.35 +0.3%
Dr. Reddy's Laboratories Ltd. 104,987.08 6,198.90 -1.5%
Zydus Lifesciences Ltd. 96,950.64 957.00 -0.7%
Mankind Pharma Ltd. 95,492.27 2,375.00 -0.4%
Torrent Pharmaceuticals Ltd. 90,980.90 2,641.10 -1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.00 1,502.30 -1.3%
Cipla Ltd. Consolidated 2023-12 30.65 1,402.20 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 76.57 3,999.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.08 6,198.90 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.60 957.00 -0.7%
Mankind Pharma Ltd. Consolidated 2023-12 55.29 2,375.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.90 2,641.10 -1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,502.30 -1.3%
Cipla Ltd. Consolidated 2023-12 4.39 1,402.20 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 8.12 3,999.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.91 6,198.90 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.14 957.00 -0.7%
Mankind Pharma Ltd. Consolidated 2023-12 10.75 2,375.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.72 2,641.10 -1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,502.30 -1.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,402.20 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,999.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,198.90 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 957.00 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,375.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,641.10 -1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,502.30 -1.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,402.20 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,999.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,198.90 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 957.00 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,375.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,641.10 -1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,502.30 -1.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,402.20 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,999.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,198.90 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 957.00 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,375.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,641.10 -1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,502.30 -1.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,402.20 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,999.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,198.90 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 957.00 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,375.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,641.10 -1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,502.30 -1.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,402.20 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,999.35 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,198.90 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 957.00 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,375.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,641.10 -1.8%

Bandaram Pharma Packtech Ltd. FAQ's

What is Bandaram Pharma Pack share price?
Can I buy Bandaram Pharma Pack shares now?
What is the Dividend Yield of Bandaram Pharma Pack?
What is the Market Cap of Bandaram Pharma Pack?
What are the key metrics to analyse Bandaram Pharma Pack?
What is the 52 Week High and Low of Bandaram Pharma Pack?
What is the trend of Bandaram Pharma Pack share price?